Nausea and Vomiting: Clinical Trials

4 trials for Nausea and Vomiting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Terminated 1, Unknown 1
Phase 21Completed 1

Follow Nausea and Vomiting: new trials by email Literature Review of Nausea and Vomiting trials Research Report on Nausea and Vomiting

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation
Glycopyrrolate, Anisodamine - Nausea and Vomiting
Phase 1 / Phase 2CompletedJie Chen1302023-10-012024-09-05
A Clinical Study to Evaluate Cyclopofol Injection for the Prevention of Postoperative Nausea and Vomiting
Heptaflurane combined Cyclophenol, Heptaflurane, Cyclophenol - Nausea and Vomiting
Phase 1UnknownMengchang Yang3002023-08-022023-07-27
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
methadone hydrochloride, questionnaire administration, management of therapy complications - Nausea and Vomiting, Pain
Phase 1TerminatedNCIC Clinical Trials Group82010-06-172024-02-12
Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer
aprepitant, cyclophosphamide, placebo - Breast Cancer, Nausea and Vomiting
Phase 1CompletedUNC Lineberger Comprehensive Cancer Center192005-08-012024-11-04

Narrower conditions

Nausea (4)  ·  Vomiting (4)  ·  Breast Neoplasms (1)  ·  Pain (1)  ·  Sleep Wake Disorders (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Signs and Symptoms, Digestive (4)  ·  Breast Diseases (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Aprepitant (1)  ·  Cyclophosphamide (1)  ·  Glycopyrrolate (1)  ·  Methadone (1)  ·  anisodamine (1)

Sponsors

Jie Chen (1)  ·  Mengchang Yang (1)  ·  NCIC Clinical Trials Group (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)

Countries

China (2)  ·  Canada (1)  ·  United States (1)

Top investigators

Bruno Gagnon, MD, MSC (1)  ·  Christine M. Walko, PharmD, BCOP (1)  ·  Guangyou Duan, doctor (1)  ·  Ray Viola (1)

Results publications

PMID 22245954

NIH funding

P30CA016086 (1)